Skip to main content
Clinical Trials/NCT00291590
NCT00291590
Completed
Phase 3

Phase 3 Randomized Controlled Trial of the Diabetes Health Enhancement Program for Medicaid and Dual Eligibles in South King County, Washington

Robert Wood Johnson Foundation1 site in 1 country146 target enrollmentJuly 2001
ConditionsDiabetes

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Diabetes
Sponsor
Robert Wood Johnson Foundation
Enrollment
146
Locations
1
Primary Endpoint
Reduction in glycated hemoglobin levels
Status
Completed
Last Updated
20 years ago

Overview

Brief Summary

Management of chronic diseases, such as diabetes, relies upon the health care providers and the patients self-care. Self management programs for diabetes that target self-empowerment tools have been found to be effective in some studies, but have not typically included individuals on Medicaid.

Our goal for this trial was to observe if patients participating in such a program could decrease glycated hemoglobin levels, improve health status and improve self-care practices.

Detailed Description

Design, Setting and Population: A Phase 3, one year prospective trial, randomized to intervention or control (usual care) with Medicaid or dual-Medicare beneficiaries, with diabetes, aged 40-85 years old residing in South King County, Washington. Intervention: A targeted, multi-component, self-management program incorporating a stage-of-change approach to overcome barriers and facilitate life-style behavior changes to achieve patient-driven health action plans for nutrition or exercise goals. Main Outcome Measures: Glycemic control (HbA1c), physical and mental health, self-care practices. Recruitment Status: Completed: participants are no longer being recruited; data analysis is complete.

Registry
clinicaltrials.gov
Start Date
July 2001
End Date
August 2003
Last Updated
20 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Robert Wood Johnson Foundation

Eligibility Criteria

Inclusion Criteria

  • Insured under Medicaid (SSI) or dual enrolled under Medicaid and Medicare for at least one year
  • Diagnosed type 1 or type 2 diabetes for at least 1 year (\>1 inpatient or \>2 outpatients visits with ICD-9 codes 250.00-250.9x, or prescriptions for insulin and/or oral hyperglycemic medications)
  • Aged 40-85 years
  • Geographically close to the Southeast Senior Center in South King County, Washington, and have a primary care provider (not HMO).

Exclusion Criteria

  • Serious kidney disease (serum creatinine \>2.5 or end-stage renal disease)
  • Other serious illness that would preclude one-year study participation (dementia, terminal illness, organ transplantation)
  • Pregnancy
  • Inability to given informed consent.

Outcomes

Primary Outcomes

Reduction in glycated hemoglobin levels

Secondary Outcomes

  • Improvement in health status and diabetes self-care practices

Study Sites (1)

Loading locations...

Similar Trials